These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 27587550)
1. The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis. Sotgiu G; Nahid P; Loddenkemper R; Abubakar I; Miravitlles M; Migliori GB Eur Respir J; 2016 Oct; 48(4):963-971. PubMed ID: 27587550 [No Abstract] [Full Text] [Related]
2. Announcement: Clinical Practice Guidelines Published for Treatment of Drug-Susceptible Tuberculosis. MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(32):831. PubMed ID: 27537009 [TBL] [Abstract][Full Text] [Related]
3. Connecting the DOTS to treat pulmonary TB. Sheff B; Hayes DD Nursing; 2005 Oct; 35(10):24-5. PubMed ID: 16205248 [No Abstract] [Full Text] [Related]
4. Multidrug resistant tuberculous meningitis in the United States, 1993-2005. Vinnard C; Winston CA; Wileyto EP; MacGregor RR; Bisson GP J Infect; 2011 Sep; 63(3):240-2. PubMed ID: 21784099 [No Abstract] [Full Text] [Related]
5. The use of adjunctive corticosteroids in the treatment of pericardial, pleural and meningeal tuberculosis: do they improve outcome? Evans DJ Respir Med; 2008 Jun; 102(6):793-800. PubMed ID: 18407484 [TBL] [Abstract][Full Text] [Related]
6. ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword? Chang KC; Yew WW Am J Respir Crit Care Med; 2020 Sep; 202(5):777-778. PubMed ID: 32374633 [No Abstract] [Full Text] [Related]
8. CDC calls for tuberculosis screening and treatment for all patients with HIV infection. Rose VL Am Fam Physician; 1999 Mar; 59(6):1682, 1687. PubMed ID: 10193602 [No Abstract] [Full Text] [Related]
10. Failure to mention fixed-dose drug combinations in the ATS/CDC/IDSA tuberculosis control statement. Moulding T Am J Respir Crit Care Med; 2006 Mar; 173(6):684; author reply 684-5. PubMed ID: 16522766 [No Abstract] [Full Text] [Related]
11. Statements of ATS, CDC, and IDSA on treatment of tuberculosis. Caminero JA; de March P Am J Respir Crit Care Med; 2004 Jan; 169(2):316-7; author reply 317. PubMed ID: 14718245 [No Abstract] [Full Text] [Related]
12. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of tuberculous meningitis in HIV-infected pediatric patients. Rowe JS; Shah SS; Marais BJ; Steenhoff AP Pediatr Infect Dis J; 2009 Feb; 28(2):147-8. PubMed ID: 19174688 [No Abstract] [Full Text] [Related]
14. New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Now Comes the Hard Part. Metersky ML; Schluger NW Am J Respir Crit Care Med; 2016 Oct; 194(7):791-793. PubMed ID: 27556737 [No Abstract] [Full Text] [Related]
15. Revised treatment and testing guidelines for latent tuberculosis infection. Rep Med Guidel Outcomes Res; 2000 Apr; 11(9):9-10. PubMed ID: 11770514 [No Abstract] [Full Text] [Related]
16. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433 [TBL] [Abstract][Full Text] [Related]
17. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 2):S221-47. PubMed ID: 10764341 [No Abstract] [Full Text] [Related]
18. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. Mayosi BM; Wiysonge CS; Ntsekhe M; Volmink JA; Gumedze F; Maartens G; Aje A; Thomas BM; Thomas KM; Awotedu AA; Thembela B; Mntla P; Maritz F; Blackett KN; Nkouonlack DC; Burch VC; Rebe K; Parish A; Sliwa K; Vezi BZ; Alam N; Brown BG; Gould T; Visser T; Shey MS; Magula NP; Commerford PJ BMC Infect Dis; 2006 Jan; 6():2. PubMed ID: 16396690 [TBL] [Abstract][Full Text] [Related]
19. A prospective investigation into the effect of colchicine on tuberculous pericarditis. Liebenberg JJ; Dold CJ; Olivier LR Cardiovasc J Afr; 2016; 27(6):350-355. PubMed ID: 27965998 [TBL] [Abstract][Full Text] [Related]
20. CDC Grand Rounds: the TB/HIV syndemic. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(26):484-9. PubMed ID: 22763886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]